Page last updated: 2024-09-05

sorafenib and poloxalene

sorafenib has been researched along with poloxalene in 1 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (poloxalene)	Trials (poloxalene)	Recent Studies (post-2010) (poloxalene)
6,520	730	5,251	660	21	149

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, S; Chen, L; Gan, H; Li, A; Liang, Y; Liu, X; Sui, X; Tang, X; Wang, D; Wu, B; Zhang, Y; Zou, S	1

Other Studies

1 other study(ies) available for sorafenib and poloxalene

Article	Year
Enhanced delivery of sorafenib with anti-GPC3 antibody-conjugated TPGS-b-PCL/Pluronic P123 polymeric nanoparticles for targeted therapy of hepatocellular carcinoma. Materials science & engineering. C, Materials for biological applications, 2018, Oct-01, Volume: 91 Topics: Animals; Antineoplastic Agents, Immunological; Carcinoma, Hepatocellular; Drug Delivery Systems; HeLa Cells; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Nude; Nanoparticles; Poloxalene; Polyesters; Sorafenib; Xenograft Model Antitumor Assays	2018

Article

Year

Enhanced delivery of sorafenib with anti-GPC3 antibody-conjugated TPGS-b-PCL/Pluronic P123 polymeric nanoparticles for targeted therapy of hepatocellular carcinoma.

Materials science & engineering. C, Materials for biological applications, 2018, Oct-01, Volume: 91

Topics: Animals; Antineoplastic Agents, Immunological; Carcinoma, Hepatocellular; Drug Delivery Systems; HeLa Cells; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Nude; Nanoparticles; Poloxalene; Polyesters; Sorafenib; Xenograft Model Antitumor Assays

2018